Abstract

Canine Public Servants: Caring for Drug Detection Dogs

Author(s): Davidson Gigi S

Issue: Sep/Oct 2008 - Veterinary Compounding

Page(s): 384-390

Download in electronic PDF format for $75
  • Canine Public Servants: Caring for Drug Detection Dogs Page 1
  • Canine Public Servants: Caring for Drug Detection Dogs Page 2
  • Canine Public Servants: Caring for Drug Detection Dogs Page 3
  • Canine Public Servants: Caring for Drug Detection Dogs Page 4
  • Canine Public Servants: Caring for Drug Detection Dogs Page 5
  • Canine Public Servants: Caring for Drug Detection Dogs Page 6
  • Canine Public Servants: Caring for Drug Detection Dogs Page 7

Abstract

DOGS ARE UTILIZED MORE AND MORE TO SEEK OUT ILLICIT AND HAZARDOUS SUBSTANCES UNDER THE GUIDANCE OF HUMANS. THEREFORE, VETERINARIANS, DOG HANDLERS, AND PHARMACISTS MUST ALL COLLABORATE TO ENSURE ADEQUATE PROTECTION, TREATMENT, AND CARE FOR DETECTION DOGS IN THE LINE OF DUTY. IDEALLY, VETERINARIANS AND PHARMACISTS CAN WORK TOGETHER TO TRAIN AND EQUIP DOG HANDLERS WITH STATE OF THE ART INSTRUCTIONS AND ANIMAL EMERGENCY KITS THAT CAN PROVIDE LIFE-SAVING DECONTAMINATION AT THE SITE OF EXPOSURE. PHARMACISTS CAN COLLABORATE WITH VETERINARIANS TO PROVIDE ANIMAL EMERGENCY KITS CONTAINING ESSENTIAL TREATMENT AIDS SUCH AS APOMORPHINE, HYDROGEN PEROXIDE, ACTIVATED CHARCOAL/SORBITOL CATHARTIC SUSPENSION, OCULAR IRRIGANTS, AND INSTRUCTIONS AND ASSOCIATED DEVICES FOR ADMINISTRATION. IMMEDIATE INTERVENTION PROVIDES THE BEST PROGNOSIS FOR CANINE HEROES THAT SUFFER EXPOSURE TO OCCUPATIONAL TOXICOLOGICAL HAZARDS.

Related Keywords

  • drug detection dogs
  • canines
  • hazardous substances
  • irritants
  • veterinary medicine
  • toxic exposures
  • decontamination
  • dog handlers
  • apomorphine
  • hydrogen peroxide
  • charcoal
  • sorbitol
  • emetics
  • cathartic suspension
  • adsorptive agents
  • ocular irrigants
  • irrigation
  • formulation

Related Categories

  • FORMULATIONS
  • VETERINARY
  • ADVERSE DRUG EVENTS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2008
Pg. 384-390
Canine Public Servants: Caring for Drug Detection Dogs
Author(s): Davidson Gigi S
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Jan/Feb 2011
Pg. 74-77
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Author(s): Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
Sep/Oct 2012
Pg. 369-375
Medical Therapy for Acquired Urinary Incontinence in Dogs
Author(s): Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Mar/Apr 2021
Pg. 143
Canine Soft Chew Base (Veterinary)
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 131-133
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs
Author(s): Burke John, Hill Jeff
Mar/Apr 2007
Pg. 149-151
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Author(s): Allen Loyd V Jr
Nov/Dec 2000
Pg. 468-470
Estrogen Use in Dogs: Indications and Complications
Author(s): Davidson Gigi S
Sep/Oct 2002
Pg. 332-336
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Author(s): Davidson Gigi S
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito
Jan/Feb 2011
Pg. 27-31
Goliath: Case Report on a Canine Case of Epilepsy
Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 182-186
How to Develop and Maintain a Hazardous Drug List
Author(s): Dillon L Rad
Sep/Oct 2019
Pg. 358-364
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Author(s): Pope George, Daleo Charles, Batson SL
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane